{"id":"W2790006193","doi":"10.1093/annonc/mdy023","title":"Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Gastroenterology; Adverse effect; Population; Ovarian cancer; Confidence interval; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00132085,0.001404753,0.002424059,0.0004178982,0.0002880759,0.001010244,0.0008386269,0.001234017,0.004048428],"category_scores_gemma":[0.0011301,0.0006879813,0.001375697,0.0003846681,0.0011513,0.001348121,0.0003388678,0.00296534,0.0007824207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007742908,"about_ca_system_score_gemma":0.0008482311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000771047,"about_ca_topic_score_gemma":0.001781446,"domain_scores_codex":[0.9995953,0.0002035607,0.00002018035,0.00007600249,0.00002991927,0.00007508265],"domain_scores_gemma":[0.9993561,0.0001767347,0.000110328,0.00005738972,0.00003492606,0.0002646236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9540839,0.01337885,0.000663268,0.0003468306,0.0007785396,0.00003528679,0.00006671232,0.0005696189,0.007400868,0.0001028049,0.0005068149,0.02206658],"study_design_scores_gemma":[0.8052585,0.1890255,0.002483991,0.00001997022,0.0005269726,0.0000459552,0.00003275814,0.0007392797,0.001002448,0.0001154166,0.000730711,0.00001838268],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947258,0.002028305,0.0004233165,0.0003163276,0.0002244727,0.000894886,0.0003566963,0.00006844052,0.0009618441],"genre_scores_gemma":[0.9927483,0.0017715,0.0009349262,0.0004472454,0.0002310151,0.001047219,0.0006130424,0.00002270633,0.002184052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004048428,"threshold_uncertainty_score":0.01354337,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0897298999838671,"score_gpt":0.462349361693235,"score_spread":0.3726194617093679,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}